- Home
- BMRN vs SWK Comparison
BMRN vs SWK Comparison
Compare BMRN & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | SWK |
|---|---|---|
| Founded | 1996 | 1843 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 11.1B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMRN | SWK |
|---|---|---|
| Price | $53.19 | $72.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 9 |
| Target Price | $88.42 | ★ $92.25 |
| AVG Volume (30 Days) | ★ 3.0M | 1.5M |
| Earning Date | 10-27-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 4.58% |
| EPS Growth | ★ 59.53 | N/A |
| EPS | 2.68 | ★ 2.90 |
| Revenue | $3,094,001,000.00 | ★ $15,166,300,000.00 |
| Revenue This Year | $13.39 | $0.05 |
| Revenue Next Year | $7.57 | $3.01 |
| P/E Ratio | ★ $19.92 | $25.02 |
| Revenue Growth | ★ 12.39 | N/A |
| 52 Week Low | $50.76 | $53.91 |
| 52 Week High | $73.51 | $91.06 |
Technical Indicators
Market Signals| Indicator | BMRN | SWK |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 60.67 |
| Support Level | $53.03 | $69.27 |
| Resistance Level | $54.66 | $72.20 |
| Average True Range (ATR) | 1.45 | 2.14 |
| MACD | -0.11 | 0.82 |
| Stochastic Oscillator | 31.61 | 91.22 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.